114 related articles for article (PubMed ID: 2320899)
21. Optimization of radiotherapy. Report of a WHO meeting of investigators.
World Health Organ Tech Rep Ser; 1980; 644():1-89. PubMed ID: 6770556
[No Abstract] [Full Text] [Related]
22. Volume correction factor in time dose relationships in brachytherapy.
Supe SJ; Sasane JB; Gupta MK
Strahlenther Onkol; 1987 May; 163(5):309-13. PubMed ID: 3589957
[TBL] [Abstract][Full Text] [Related]
23. [Low dose rate accelerated radiation therapy].
Pierquin B; Tubiana M;
Cancer Radiother; 2007 Dec; 11(8):441-2. PubMed ID: 18029215
[No Abstract] [Full Text] [Related]
24. [Importance of the value of the dose fraction and the time factor in radiation therapy].
Zholkiver KI
Med Radiol (Mosk); 1986 Mar; 31(3):72-9. PubMed ID: 3515108
[No Abstract] [Full Text] [Related]
25. Quality assurance of radiotherapy in clinical trials.
Glicksman AS; Reinstein LE; Laurie F
Cancer Treat Rep; 1985 Oct; 69(10):1199-205. PubMed ID: 4042099
[No Abstract] [Full Text] [Related]
26. [Heterogeneity of neoplasms, radiosensitivity interval and optimal therapeutic dose].
Kholin VV
Med Radiol (Mosk); 1975 Jan; 20(1):52-4. PubMed ID: 1128194
[No Abstract] [Full Text] [Related]
27. [The role of in vivo dosimetry in radiotherapy].
Lagrange JL; Noël A
Bull Cancer Radiother; 1994; 81(4):456-62. PubMed ID: 7702934
[No Abstract] [Full Text] [Related]
28. [Evaluation of radiosensitivity of neoplasms].
Lavnikova GA
Med Radiol (Mosk); 1973 Dec; 18(12):68-70. PubMed ID: 4790963
[No Abstract] [Full Text] [Related]
29. Radiation exposure of personnel during intraoperative radiotherapy (IORT): radiation protection aspects.
Strigari L; Soriani A; Landoni V; Teodoli S; Bruzzaniti V; Benassi M
J Exp Clin Cancer Res; 2004 Sep; 23(3):489-94. PubMed ID: 15595641
[TBL] [Abstract][Full Text] [Related]
30. The relationships of radiobiology to radiotherapy.
van den Brenk HA
Curr Top Radiat Res Q; 1973 Oct; 9(1):86-93. PubMed ID: 4128666
[No Abstract] [Full Text] [Related]
31. [Optimization of the timing of dose distribution in radiation therapy].
Kozlov AP; Afanas'ev BP; Antonevich OV; Akimov AA
Med Radiol (Mosk); 1985 Jun; 30(6):49-52. PubMed ID: 4021753
[No Abstract] [Full Text] [Related]
32. [Documentation of external radiotherapy in tumor diseases].
Möller TR; Nordberg UB
Lakartidningen; 1972 Nov; 69(48):5625-30. PubMed ID: 4119500
[No Abstract] [Full Text] [Related]
33. [Intracellular recovery--basis of hyperfractionation].
Hagen U; Guttenberger R; Kummermehr J
Strahlenther Onkol; 1988 Nov; 164(11):653-6. PubMed ID: 3059550
[TBL] [Abstract][Full Text] [Related]
34. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
35. Hyperfractionation.
Withers HR; Peters LJ; Thames HD; Fletcher GH
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1807-9. PubMed ID: 7153093
[No Abstract] [Full Text] [Related]
36. [Use of hyperbaric oxygenation in radiotherapy of patients with malignant tumors].
Dar'ialova SL
Sov Med; 1983; (7):49-54. PubMed ID: 6353608
[No Abstract] [Full Text] [Related]
37. [Dose-time optimization in fractionated radiotherapy].
Kriester A; Kloetzer KH; Kob D
Strahlenther Onkol; 1988 Aug; 164(8):489-98. PubMed ID: 3138769
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional treatment planning and conformal radiation dose delivery.
Lichter AS; Ten Haken RK
Important Adv Oncol; 1995; ():95-109. PubMed ID: 7672816
[TBL] [Abstract][Full Text] [Related]
39. [Formation of optimum dose fields in contact radiation therapy of malignant tumors].
Klepper LIa
Med Tekh; 2003; (2):38-44. PubMed ID: 12924220
[TBL] [Abstract][Full Text] [Related]
40. [Radiobiology of injuries of the pelvic structures].
Magno L
Arch Ital Urol Nefrol Androl; 1988 Dec; 60(4):353-5. PubMed ID: 2977663
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
